Hence, taken together with previous findings, our findings suggest that AD-associated pathology, conferred by APOE4, may interact with non–AD-specific pathology, conferred by NfL, in the association with accelerated cognitive decline. This evidence concerns the gene APOE and Alzheimer disease.